Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Intuitive expands push into cardiac market with CE mark

25 September 2026 · By · Wire by Fusion42

Published

25 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

Europe

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 25 September 2026 · Fusion42 review

Intuitive has received CE mark approval to expand its surgical robotics technology into the cardiac market, focusing on cardiovascular disease treatment after deprioritizing heart surgery previously.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 25 Sep 2026 and 29 Sep 2026.

◆ ◆ The Wire takeaway

You can now offer advanced robotic solutions in heart surgery within the EU thanks to Intuitive’s CE mark; this opens doors to a large cardiovascular treatment market that was previously less accessible. Evaluate your product roadmap to integrate or compete with robotic cardiac surgery platform capabilities soon.

◆ Coverage

2 sources · first reported 25 Sep 2026 · latest 29 Sep 2026

◆ Related on Wire

◆ Topics

Medtechce-markcardiac-marketsurgical-robotmedtecheu-regulation